Caprion Biosciences Expands its Biomarker and Immune Monitoring Franchise by Acquiring US-Based Primity Bio.
London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges today’s announcement from its portfolio company Caprion Biosciences, Inc. (“Caprion” or “the Company”) regarding the acquisition of US-based Primity Bio. Caprion Biosciences announced today that the company acquired Primity Bio Inc., a specialised provider of biomarker and immune monitoring services located in Fremont,… read more
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, today announces the sale of Caprion Biosciences (“Caprion”) to Arsenal Capital Partners, a leading specialised private equity firm that invests in middle-market healthcare and specialty industrials companies. Caprion is a specialised laboratory service business serving pharma and biotech… read more
Caprion Biosciences expands its global biomarker and immune monitoring franchise by acquiring Serametrix Corporation
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company, Caprion BioSciences, regarding the acquisition of Serametrix Corporation. Caprion Biosciences announced that the company acquired Serametrix Corporation, a specialised provider of immune monitoring services headquartered in Carlsbad, California. Caprion plans to… read more